Other Assets

9 Months Ended

Dec. 31, 2021

Other Assets [Abstract]

Other Assets

Note 10. Other Assets

The components of other assets are as follows:

	December 31, 2021		March 31, 2021
	(in thousands)
Investment in Shockwave Medical	$	52,920	$	38,655
Other investments (Note 6)		58,619		62,995
Operating lease right of use asset (Note 11)		9,069		6,109
Other intangible assets and other assets		6,341		5,323
Total other assets	$	126,949	$	113,082

Investment in Shockwave Medical

During the three months ended December 31, 2021 and 2020, the Company recorded a loss of $8.2 million and a gain of $8.3 million, respectively in other (loss) income, net. During the nine months ended December 31, 2021 and 2020, the Company recorded gains of $14.3 million and $43.0 million, respectively, in other (loss) income, net. During the nine months ended December 31, 2020, the Company sold approximately 1.4 million of its shares in Shockwave Medical for cash proceeds of $67.9 million and recognized a gain of $47.3 million.

Other Intangible Assets and Other Assets

The Company’s other intangible assets and other assets is comprised primarily of license manufacturing rights to certain technology from third parties and other long-term assets such as from third parties and other long-term assets such as prepayments related to the Company’s clinical trial activities.